BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35610300)

  • 1. Comprehensive analysis of 65 patients with Castleman disease in a single center in China.
    Wang XQ; Zhong NN; Sun Q; Yan SC; Xu GC; Wang YG; Peng LW; Liu B; Bu LL
    Sci Rep; 2022 May; 12(1):8694. PubMed ID: 35610300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
    Nabel CS; Sameroff S; Shilling D; Alapat D; Ruth JR; Kawano M; Sato Y; Stone K; Spetalen S; Valdivieso F; Feldman MD; Chadburn A; Fosså A; van Rhee F; Lipkin WI; Fajgenbaum DC
    PLoS One; 2019; 14(6):e0218660. PubMed ID: 31242229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital.
    González-García A; Patier de la Peña JL; García-Cosio M; Sarhane Y; Sánchez Díaz C; Barbolla Díaz I; López Rodríguez M; Moreno MÁ; Villarubia J; Manzano L
    Leuk Lymphoma; 2019 Dec; 60(14):3442-3448. PubMed ID: 31305183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study.
    Sopfe J; Endres A; Campbell K; Hayes K; Trout AT; Liang X; Lorsbach R; O'Brien MM; Cost CR
    Pediatr Blood Cancer; 2019 May; 66(5):e27613. PubMed ID: 30680887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and treatment outcomes of Castleman disease in children: a retrospective cohort in China.
    Hu S; Li Z; Wang H; Chen L; Ma Y; Zhu X; Li J; Dong R; Yao W; Dong C; Zhang H; Li K; Dong K; Zhai X
    Eur J Pediatr; 2023 Dec; 182(12):5519-5530. PubMed ID: 37782352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients.
    Leite JM; Barrese TZ; Sementilli L; de Freitas LLL; do Espirito Santo KS; Delamain MT; Baiocchi OCCG; Brasil SAB; Chiattone CS
    Ann Hematol; 2023 May; 102(5):1121-1129. PubMed ID: 36763110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
    van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
    Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The French paediatric cohort of Castleman disease: a retrospective report of 23 patients.
    Borocco C; Ballot-Schmit C; Ackermann O; Aladjidi N; Delaleu J; Giacobbi-Milet V; Jannier S; Jeziorski E; Maurier F; Perel Y; Piguet C; Oksenhendler E; Koné-Paut I; Galeotti C
    Orphanet J Rare Dis; 2020 Apr; 15(1):95. PubMed ID: 32303241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Castleman Disease.
    Simpson D
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):1-10. PubMed ID: 29157611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease.
    Yu L; Tu M; Cortes J; Xu-Monette ZY; Miranda RN; Zhang J; Orlowski RZ; Neelapu S; Boddu PC; Akosile MA; Uldrick TS; Yarchoan R; Medeiros LJ; Li Y; Fajgenbaum DC; Young KH
    Blood; 2017 Mar; 129(12):1658-1668. PubMed ID: 28100459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
    Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
    Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of Castleman disease.
    Dispenzieri A; Fajgenbaum DC
    Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
    Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
    Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
    [No Abstract]   [Full Text] [Related]  

  • 14. The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.
    Pelliccia S; Rogges E; Cardoni A; Lopez G; Conte E; Faccini AL; De Vito R; Girardi K; Bianchi A; Annibali O; Fratoni S; Remotti D; De Angelis G; Giordano C; Palumbo G; Scarpino S; Del Porto F; Bianchi MP; Di Gregorio F; Tafuri A; Di Napoli A
    Br J Haematol; 2024 Feb; 204(2):534-547. PubMed ID: 37953489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
    Zhang L; Dong YJ; Peng HL; Li H; Zhang MZ; Wang HH; Liu QH; Su LP; Zhong LY; Wu WJ; Huang L; Yan XJ; Fan L; Tang WJ; Li ZL; Bi LT; Li Y; Gao GX; Gao L; Liu TB; Wei YQ; Liu Y; Yu L; Zhou H; Sun CY; Qian WB; Zou DH; Zhang HL; Ding KY; Wang XB; Bai O; Huang WR; Chen B; Yang L; Song J; Gao D; Chen T; Luo J; Wang SY; Ma LM; Fajgenbaum DC; Li J;
    Lancet Reg Health West Pac; 2023 May; 34():100720. PubMed ID: 37283978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms.
    Fraticelli S; Lucioni M; Neri G; Marchiori D; Cristinelli C; Merli M; Monaco R; Borra T; Lazzaro A; Uccella S; Arcaini L; Paulli M
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital.
    Luo JM; Li S; Huang H; Cao J; Xu K; Bi YL; Feng RE; Huang C; Qin YZ; Xu ZJ; Xiao Y
    BMC Pulm Med; 2015 Apr; 15():34. PubMed ID: 25886851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castleman Disease: A Multicenter Case Series from Turkey.
    Gündüz E; Kırkızlar HO; Ümit EG; Karaman Gülsaran S; Özkocaman V; Özkalemkaş F; Candar Ö; Elverdi T; Küçükyurt S; Paydaş S; Çeneli Ö; Karakuş S; Maral S; Ekinci Ö; İpek Y; Kis C; Güven ZT; Akdeniz A; Celkan T; Eroğlu Küçükdiler AH; Akgün Çağlıyan G; Özçelik Şengöz C; Karataş A; Bulduk T; Özcan A; Belen Apak FB; Canbolat A; Kartal İ; Ören H; Töret E; Özdemir GN; Bakanay Öztürk ŞM
    Turk J Haematol; 2022 Jun; 39(2):130-135. PubMed ID: 35176839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Bertinchamp R; Terriou L
    Rev Med Interne; 2022 Dec; 43(10S1):10S4-10S9. PubMed ID: 36657941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.
    Fayand A; Boutboul D; Galicier L; Kahn JE; Buob D; Boffa JJ; Cez A; Oksenhendler E; Grateau G; Ducharme-Bénard S; Georgin-Lavialle S
    Amyloid; 2019 Dec; 26(4):197-202. PubMed ID: 31364863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.